文献速递慢性肾脏病肾血管病与高血压

慢性肾脏病患者的肾脏去神经术:当前证据与未来展望

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

本文综述了肾脏去神经术在慢性肾脏病(CKD)患者中的最新研究。基于高质量随机对照试验和注册分析,该干预对高血压治疗安全有效,对CKD人群也有证据支持,并可能具有肾脏保护作用。

要点

  • 肾脏去神经术正成为高血压的重要辅助治疗手段。
  • CKD患者常伴交感神经过度激活,可能从去神经术额外获益。
  • 临床证据支持该治疗在CKD人群中的安全性和有效性。

核心结论

  • 肾脏去神经术是高血压安全有效的辅助治疗,对CKD患者可能提供额外获益,并可能有肾脏保护作用。

研究设计与样本

  • 综述,聚焦肾脏疾病,从肾内科医生视角评估最新研究。

主要发现

  • 多项高质量随机对照试验和注册分析支持肾脏去神经术的安全性和有效性。
  • 临床证据支持该干预在难以控制的CKD高血压人群中的安全性和有效性。
  • 临床前和临床研究提示对CKD患者可能有肾脏保护作用。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Supported by several high-quality randomized controlled trials and registry analyses, catheter-based renal denervation is becoming an important adjunctive treatment modality for the safe and efficacious treatment of hypertension besides lifestyle modifications and antihypertensive medication. Renal denervation is of particular interest to nephrologists as the intervention may provide additional benefits to hypertensive people with chronic kidney disease (CKD), a condition typically characterized by sympathetic hyperactivity. A growing body of clinical evidence supports the safety and efficacy of renal denervation in this difficult-to-control population. In addition, preclinical and clinical research works indicate potential nephroprotective effects in CKD patients. The current review examines recent research on renal denervation with a focus on renal disease and assesses the latest findings and their implications from a nephrologist's perspective.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Schmieder RE. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrol Dial Transplant. 2023. PMID: 35617138. doi:10.1093/ndt/gfac189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。